Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for Their COVID-19 Vaccine

Pfizer and BioNTech have initiated a rolling submission of a biologics license application to FDA for the approval of their COVID-19 vaccine in individuals 16 years of age and older.